Three Industry Leaders United for Better Health at CPHI Frankfurt 2025
Date: October 28–30, 2025
Location: Hall 8, Booth 8.0P2
Experience the Future of Drug Delivery Innovation with Roquette Health & Pharma Solutions Business Group
Join us at CPHI Frankfurt 2025 as we unveil the unified strength of Roquette Pharma Solutions, Qualicaps, and IFF Pharma Solutions — now integrated under the Roquette Health & Pharma Solutions Business Group. With over 75 years of pharmaceutical formulation expertise, we’re redefining drug delivery with a comprehensive portfolio of excipients, capsules, and coating technologies.
What to Expect at Our Booth
Explore our next-generation drug delivery platform through three dedicated technology focus areas, each designed to support formulation success from development to delivery.
Plus, visit our Product Sample & Innovation Showcase to experience our technologies firsthand.
Technology Focus Areas
1. Solubility & Stability Enhancement
Better Solubility. Better Stability. Better Outcomes.
Formulate more effective, patient-friendly medicines with excipients and capsules that enhance bioavailability, taste masking, and shelf life.
Featured Innovations:
- Kleptose® HPBCD – Solubility and taste masking for 70%+ APIs
- Pearlitol® Mannitol – Stability enhancer for sensitive APIs
- POLYOX™ ES Resins – Controlled release with packaging benefits
- Quali-V® HPMC Capsules – Ideal for moisture-sensitive formulations
2. Nitrosamine Risk Mitigation Strategies
Trusted Compliance. Proven Performance.
Stay compliant with global regulations using excipients and capsules engineered to reduce nitrosamine formation and meet evolving safety standards.
Featured Innovations:
- Low Nitrite METHOCEL™ HPMC – Controlled release with nitrosamine control
- Avicel® LN MCC – Binder with 100ppb nitrite specification
- Pearlitol® Mannitol – Non-hygroscopic filler for sensitive APIs
3. Smart Solutions for Release, Coating & Inhalation
Precision Drug Delivery Starts Here
Achieve targeted release and process efficiency with advanced coatings, excipients, and capsule technologies.
Featured Innovations:
- METHOCEL™ CR – Controlled release matrix tablets
- ETHOCEL™ / Aquacoat® ECD – Barrier membrane coatings
- POLYOX™ WSR – Fast-swelling polymers for osmotic systems
- ReadiLycoat® – Plant-based coating system
- Alginates – Anti-reflux, pH-controlled release
- Quali-V®-I Capsules & Pearlitol® 200 INH Mannitol – Dry powder inhalation
Three Legacies. One Purpose
The Roquette Health & Pharma Solutions Business Group represents the unified identity of Roquette’s Pharma Solutions business, now strengthened by the acquisitions of Qualicaps and IFF Pharma Solutions — reshaping drug development through trusted innovation and a comprehensive portfolio of excipients, APIs, coatings, and capsule technologies.
Our integrated offering empowers formulators to:
- Accelerate development timelines
- Enhance drug performance
- Ensure regulatory compliance
- Deliver patient-centric therapies
We go beyond ingredients — we’re your partner in innovation, compliance, and healthcare transformation.
Let’s Connect at CPHI Frankfurt
We’d love to connect and explore how we can support your next breakthrough in drug development.
Visit us at Hall 8, Booth 8.0P24
Learn more at roquette.com | pharma.iff.com